Fusion protein Cys–Asn–Gly–Arg–Cys–Gly–TNFα (NGR-TNFα), which targets the tumor vasculature delivering low amounts of TNFα, activates endothelial cells and allows CD8+ T lymphocytes infiltration (268). This evidence concerns the gene CD8A and neoplasm.